Bhalla Narinder Pal bought LXEO
September 14, 2026 · Form 4 insider transaction
Bhalla Narinder Pal bought 2,714 shares of Lexeo Therapeutics, Inc. at $3.58 per share, a transaction worth $9.7K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 14 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,714
Price
$3.58
Total value
$9.7K
InsiderBhalla Narinder Pal
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateSeptember 14, 2026
Filing dateSeptember 28, 2026
Shares owned after84,908
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Lexeo Therapeutics, Inc. 2023 Employee Stock Purchase Plan. This transaction is exempt under both Rule 16b-3(c) and Rule 16b-3(d).; Includes 49,500 Restricted Stock Units.